The Texas Liver Institute Inc
607 Camden Street, San Antonio, TX, USA 78215
Featured Trial
Primary Sclerosing Cholangitis Clinical Trial
This study is designed to assess the safety, tolerability and activity of CM-101 in patients with Primary Sclerosing Cholangitis (PSC).
Recruiting
Male & Female
18 - 75
Years old